Works matching IS 03618609 AND DT 2024 AND VI 99 AND IP 5


Results: 30
    1
    2
    3

    Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 880, doi. 10.1002/ajh.27283
    By:
    • Lunning, Matthew A.;
    • Wang, Hai‐lin;
    • Hu, Zhen‐Huan;
    • Locke, Frederick L.;
    • Siddiqi, Tanya;
    • Jacobson, Caron A.;
    • Ahmed, Sairah;
    • Miklos, David B.;
    • Lin, Yi;
    • Hill, Brian T.;
    • Ghobadi, Armin;
    • Neelapu, Sattva S.;
    • Westin, Jason;
    • Dieyi, Chrisopher;
    • Field, Polly;
    • Miao, Harry;
    • Shahani, Shilpa A.;
    • Patel, Anik;
    • Spooner, Clare;
    • Fu, Christine
    Publication type:
    Article
    4

    Detection of signature double‐negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 997, doi. 10.1002/ajh.27286
    By:
    • Eisenhauer, Nina;
    • Miano, Maurizio;
    • Naumann‐Bartsch, Nora;
    • Leyh, Jörg;
    • Dell'Orso, Gianluca;
    • Aigner, Michael;
    • Fecker, Gisela;
    • Hinze, Claas;
    • Wittkowski, Helmut;
    • Bruns, Heiko;
    • Zierk, Jakob;
    • Metzler, Markus;
    • Arkwright, Peter D.;
    • Graw, Frederik;
    • Mackensen, Andreas;
    • Völkl, Simon
    Publication type:
    Article
    5

    Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 890, doi. 10.1002/ajh.27281
    By:
    • Ciurea, Stefan O.;
    • Kongtim, Piyanuch;
    • Srour, Samer;
    • Chen, Julianne;
    • Soebbing, Doris;
    • Shpall, Elizabeth;
    • Rezvani, Katayoun;
    • Nakkula, Robin;
    • Thakkar, Aarohi;
    • Troy, Ella C.;
    • Cash, Alex A.;
    • Behbehani, Gregory;
    • Cao, Kai;
    • Schafer, Jolie;
    • Champlin, Richard E.;
    • Lee, Dean A.
    Publication type:
    Article
    6

    Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant‐ineligible patients with newly diagnosed multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 1008, doi. 10.1002/ajh.27280
    By:
    • Ludwig, Heinz;
    • Melchardt, Thomas;
    • Sormann, Siegfried;
    • Schreder, Martin;
    • Andel, Johannes;
    • Hartmann, Bernd;
    • Tinchon, Christoph;
    • Zojer, Niklas;
    • Gunsilius, Eberhard;
    • Podar, Klaus;
    • Egle, Alexander;
    • Willenbacher, Wolfgang;
    • Wöll, Ewald;
    • Ruckser, Reinhard;
    • Bozic, Boris;
    • Krauth, Maria‐Theresa;
    • Petzer, Andreas;
    • Schmitt, Clemens;
    • Machherndl‐Spandl, Sigrid;
    • Agis, Hermine
    Publication type:
    Article
    7
    8

    Pituitary apoplexy in acute promyelocytic leukemia.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 975, doi. 10.1002/ajh.27277
    By:
    • Mirvis, Eitan;
    • Sairam, Shwetha;
    • Vainieri, Erika;
    • Tona, Francesca;
    • Hockings, Catherine;
    • Palanicawandar, Renuka;
    • Nadal‐Melsio, Elisabet
    Publication type:
    Article
    9
    10
    11
    12

    CALR‐mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 1001, doi. 10.1002/ajh.27265
    By:
    • Aubin, Laura;
    • Vilas Boas, Rúben;
    • Daltro De Oliveira, Rafael;
    • Le Brun, Valoris;
    • Divoux, Marion;
    • Rey, Jérôme;
    • Mansier, Olivier;
    • Ianotto, Jean‐Christophe;
    • Pastoret, Cédric;
    • Desmares, Anne;
    • Murati, Anne;
    • de Mas, Véronique;
    • Tavitian, Suzanne;
    • Girodon, François;
    • Soret Dulphy, Juliette;
    • Maslah, Nabih;
    • Goncalves Monteiro, Valérie;
    • Boyer, Françoise;
    • Orvain, Corentin;
    • Ranta, Dana
    Publication type:
    Article
    13
    14

    Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 993, doi. 10.1002/ajh.27262
    By:
    • Polverelli, Nicola;
    • Bonneville, Edouard F.;
    • de Wreede, Liesbeth C.;
    • Koster, Linda;
    • Kröger, Nicolaus Martin;
    • Schroeder, Thomas;
    • Peffault de Latour, Régis;
    • Passweg, Jakob;
    • Sockel, Katja;
    • Broers, Annoek E. C.;
    • Clark, Andrew;
    • Dreger, Peter;
    • Blaise, Didier;
    • Yakoub‐Agha, Ibrahim;
    • Petersen, Soeren Lykke;
    • Finke, Jürgen;
    • Chevallier, Patrice;
    • Helbig, Grzegorz;
    • Rabitsch, Werner;
    • Sammassimo, Simona
    Publication type:
    Article
    15
    16
    17
    18
    19

    Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 844, doi. 10.1002/ajh.27252
    By:
    • Gagelmann, Nico;
    • Hobbs, Gabriela S.;
    • Campodonico, Edoardo;
    • Helbig, Grzegorz;
    • Novak, Polona;
    • Schroeder, Thomas;
    • Schneider, Artur;
    • Rautenberg, Christina;
    • Reinhardt, Hans Christian;
    • Bosques, Linette;
    • Heuser, Michael;
    • Panagiota, Victoria;
    • Thol, Felicitas;
    • Gurnari, Carmelo;
    • Maciejewski, Jaroslaw P.;
    • Ciceri, Fabio;
    • Rathje, Kristin;
    • Robin, Marie;
    • Pagliuca, Simona;
    • Rubio, Marie‐Thérèse
    Publication type:
    Article
    20

    Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 836, doi. 10.1002/ajh.27254
    By:
    • Khouri, Issa F.;
    • Alzahrani, Kamal;
    • Kantarjian, Hagop;
    • Milton, Denái R.;
    • Gulbis, Alison M.;
    • Sasaki, Koji;
    • Jain, Nitin;
    • Short, Nicholas J.;
    • Kadia, Tapan;
    • Daher, May;
    • Rafei, Hind;
    • Im, Jin S.;
    • Marin, David;
    • Olson, Amanda L.;
    • Popat, Uday;
    • Qazilbash, Muzaffar;
    • Ramdial, Jeremy;
    • Rondon, Gabriela;
    • Srour, Samer;
    • Kebriaei, Partow
    Publication type:
    Article
    21
    22

    Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 982, doi. 10.1002/ajh.27247
    By:
    • Autore, Francesco;
    • Visentin, Andrea;
    • Deodato, Marina;
    • Vitale, Candida;
    • Galli, Eugenio;
    • Fresa, Alberto;
    • Fazzi, Rita;
    • Sanna, Alessandro;
    • Olivieri, Jacopo;
    • Scortechini, Ilaria;
    • Del Principe, Maria Ilaria;
    • Sportoletti, Paolo;
    • Schiattone, Luana;
    • Maschio, Nilla;
    • Facchinelli, Davide;
    • Marchesi, Francesco;
    • Coscia, Marta;
    • Tedeschi, Alessandra;
    • Trentin, Livio;
    • Innocenti, Idanna
    Publication type:
    Article
    23

    Real‐world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 816, doi. 10.1002/ajh.27242
    By:
    • Griffin, Morag;
    • Kelly, Richard;
    • Brindel, Isabelle;
    • Maafa, Lynda;
    • Trikha, Roochi;
    • Muus, Petra;
    • Munir, Talha;
    • Varghese, Abraham Mullasseril;
    • Mitchell, Lindsay;
    • Nagumantry, Sateesh;
    • Gandhi, Shreyans;
    • Pike, Alex;
    • Kulasekararaj, Austin G.;
    • Peffault de Latour, Regis
    Publication type:
    Article
    24

    Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 806, doi. 10.1002/ajh.27237
    By:
    • Nishiwaki, Satoshi;
    • Sugiura, Isamu;
    • Fujisawa, Shin;
    • Hatta, Yoshihiro;
    • Atsuta, Yoshiko;
    • Doki, Noriko;
    • Kurahashi, Shingo;
    • Ueda, Yasunori;
    • Dobashi, Nobuaki;
    • Maeda, Tomoya;
    • Matsumura, Itaru;
    • Tanaka, Masatsugu;
    • Kako, Shinichi;
    • Ichinohe, Tatsuo;
    • Fukuda, Takahiro;
    • Ohtake, Shigeki;
    • Ishikawa, Yuichi;
    • Miyazaki, Yasushi;
    • Kiyoi, Hitoshi
    Publication type:
    Article
    25
    26
    27
    28
    29

    Wiskott–Aldrich syndrome.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 969, doi. 10.1002/ajh.27183
    By:
    • Pelling, Daniel;
    • Bain, Barbara J.
    Publication type:
    Article
    30

    Issue Information.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 5, p. 801, doi. 10.1002/ajh.26975
    Publication type:
    Article